Sichenzia Ross Ference Kesner LLP Represents Medovex Corp. in $4.15 Million Private Placement and Debt Conversion
Press Release – New York, NY – March 1, 2017 – Securities and corporate law firm Sichenzia Ross Ference Kesner LLP is pleased to announce that the firm has represented Medovex Corp. (NASDAQ:MDVX), a medical products manufacturer, in a private placement of units consisting of 3,071,634 shares of common stock and 1,535,817 warrants to purchase common stock at a fixed price of $1.04 per unit resulting in gross proceeds of $3,022,000.
Laidlaw & Company (UK) Ltd. acted as placement agent in the offering. In addition, the firm represented Medovex in connection with the conversion of $1,150,000 of its debt into equity on substantially the same terms. The Sichenzia Ross Ference Kesner LLP team was led by partners Harvey Kesner and Arthur Marcus and counsel Cheryll Calaguio.
Visit SRFK's LinkedIn page
Latest posts by Sichenzia Ross Ference Kesner LLP (see all)
- Sichenzia Ross Ference Kesner LLP Congratulates AYTU Biosciences, Inc., on NASDAQ Uplisting - October 19, 2017
- Sichenzia Ross Ference Kesner LLP Represents Joseph Gunnar and Fordham Financial Management in $6.75 Million Registered Direct Offering of Common Stock of Ampio Pharmaceuticals, Inc. - October 18, 2017
- Sichenzia Ross Ference Kesner LLP Advises US Gold Corp. on $2.5 Million Public Offering - October 13, 2017